645 related articles for article (PubMed ID: 34431682)
21. Complementary autophagy inhibition and glucose metabolism with rattle-structured polydopamine@mesoporous silica nanoparticles for augmented low-temperature photothermal therapy and
Shao L; Li Y; Huang F; Wang X; Lu J; Jia F; Pan Z; Cui X; Ge G; Deng X; Wu Y
Theranostics; 2020; 10(16):7273-7286. PubMed ID: 32641992
[TBL] [Abstract][Full Text] [Related]
22. Targeted polydopamine nanoparticles enable photoacoustic imaging guided chemo-photothermal synergistic therapy of tumor.
Li Y; Jiang C; Zhang D; Wang Y; Ren X; Ai K; Chen X; Lu L
Acta Biomater; 2017 Jan; 47():124-134. PubMed ID: 27721008
[TBL] [Abstract][Full Text] [Related]
23. Pt@polydopamine nanoparticles as nanozymes for enhanced photodynamic and photothermal therapy.
Cao H; Yang Y; Liang M; Ma Y; Sun N; Gao X; Li J
Chem Commun (Camb); 2021 Jan; 57(2):255-258. PubMed ID: 33306071
[TBL] [Abstract][Full Text] [Related]
24. Photosensitizer-Conjugated Hyaluronic Acid-Shielded Polydopamine Nanoparticles for Targeted Photomediated Tumor Therapy.
Han J; Park W; Park SJ; Na K
ACS Appl Mater Interfaces; 2016 Mar; 8(12):7739-47. PubMed ID: 26965036
[TBL] [Abstract][Full Text] [Related]
25. Oxygen-independent combined photothermal/photodynamic therapy delivered by tumor acidity-responsive polymeric micelles.
Han Y; Chen Z; Zhao H; Zha Z; Ke W; Wang Y; Ge Z
J Control Release; 2018 Aug; 284():15-25. PubMed ID: 29894709
[TBL] [Abstract][Full Text] [Related]
26. Construction of Surface-Modified Polydopamine Nanoparticles for Sequential Drug Release and Combined Chemo-Photothermal Cancer Therapy.
Wei C; Wang P; Huang Z; He D; Zhu W; Liu H; Chen Z; Wang W; Li Y; Shen J; Qin L
Mol Pharm; 2021 Mar; 18(3):1327-1343. PubMed ID: 33530691
[TBL] [Abstract][Full Text] [Related]
27. Novel Oxygen-Deficient Zirconia (ZrO
Sun L; Jiao X; Liu W; Wang Y; Cao Y; Bao SJ; Xu Z; Kang Y; Xue P
ACS Appl Mater Interfaces; 2019 Nov; 11(44):41127-41139. PubMed ID: 31610123
[TBL] [Abstract][Full Text] [Related]
28. Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro.
Jędrzak A; Grześkowiak BF; Golba K; Coy E; Synoradzki K; Jurga S; Jesionowski T; Mrówczyński R
Int J Nanomedicine; 2020; 15():7923-7936. PubMed ID: 33116509
[TBL] [Abstract][Full Text] [Related]
29. PSMA-targeted melanin-like nanoparticles as a multifunctional nanoplatform for prostate cancer theranostics.
Dai L; Shen G; Wang Y; Yang P; Wang H; Liu Z
J Mater Chem B; 2021 Jan; 9(4):1151-1161. PubMed ID: 33434248
[TBL] [Abstract][Full Text] [Related]
30. Pd@Au Bimetallic Nanoplates Decorated Mesoporous MnO
Zhang Y; Lv F; Cheng Y; Yuan Z; Yang F; Liu C; Cao Y; Zhang K; Lu H; Zada S; Guo S; Dong H; Zhang X
Adv Healthc Mater; 2020 Jan; 9(2):e1901528. PubMed ID: 31820854
[TBL] [Abstract][Full Text] [Related]
31. A porous material excited by near-infrared light for photo/chemodynamic and photothermal dual-mode combination therapy.
Sun M; Yang D; Sun Q; Jia T; Kuang Y; Gai S; He F; Zhang F; Yang P
J Mater Chem B; 2020 Dec; 8(46):10559-10576. PubMed ID: 32939520
[TBL] [Abstract][Full Text] [Related]
32. Multifunctional theranostic agents based on prussian blue nanoparticles for tumor targeted and MRI-guided photodynamic/photothermal combined treatment.
Lin X; Cao Y; Xue Y; Wu F; Yu F; Wu M; Zhu X
Nanotechnology; 2020 Mar; 31(13):135101. PubMed ID: 31783383
[TBL] [Abstract][Full Text] [Related]
33. Tumor-targeting photodynamic therapy based on folate-modified polydopamine nanoparticles.
Yan S; Huang Q; Chen J; Song X; Chen Z; Huang M; Xu P; Zhang J
Int J Nanomedicine; 2019; 14():6799-6812. PubMed ID: 31692522
[TBL] [Abstract][Full Text] [Related]
34. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
35. Combined Cancer Chemo-Photodynamic and Photothermal Therapy Based on ICG/PDA/TPZ-Loaded Nanoparticles.
Huang X; Wu J; He M; Hou X; Wang Y; Cai X; Xin H; Gao F; Chen Y
Mol Pharm; 2019 May; 16(5):2172-2183. PubMed ID: 30978027
[TBL] [Abstract][Full Text] [Related]
36. Drug-Controlled Release Based on Complementary Base Pairing Rules for Photodynamic-Photothermal Synergistic Tumor Treatment.
Zhan Q; Shi X; Zhou J; Zhou L; Wei S
Small; 2019 Jan; 15(3):e1803926. PubMed ID: 30488638
[TBL] [Abstract][Full Text] [Related]
37. Redox-responsive prodrug-like PEGylated macrophotosensitizer nanoparticles for enhanced near-infrared imaging-guided photodynamic therapy.
Ruan Z; Yuan P; Li T; Tian Y; Cheng Q; Yan L
Eur J Pharm Biopharm; 2019 Feb; 135():25-35. PubMed ID: 30550923
[TBL] [Abstract][Full Text] [Related]
38. Polydopamine-Based Nanoparticles for Photothermal Therapy/Chemotherapy and their Synergistic Therapy with Autophagy Inhibitor to Promote Antitumor Treatment.
Lu J; Cai L; Dai Y; Liu Y; Zuo F; Ni C; Shi M; Li J
Chem Rec; 2021 Apr; 21(4):781-796. PubMed ID: 33634962
[TBL] [Abstract][Full Text] [Related]
39. Copper Ion and Ruthenium Complex Codoped Polydopamine Nanoparticles for Magnetic Resonance/Photoacoustic Tomography Imaging-Guided Photodynamic/Photothermal Dual-Mode Therapy.
Zhang M; Wang L; Liu H; Wang Z; Feng W; Jin H; Liu S; Lan S; Liu Y; Zhang H
ACS Appl Bio Mater; 2022 May; 5(5):2365-2376. PubMed ID: 35507759
[TBL] [Abstract][Full Text] [Related]
40. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
